Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors
- PMID: 11745222
- PMCID: PMC2610318
- DOI: 10.1002/1097-0142(20010915)92:6<1451::aid-cncr1469>3.0.co;2-r
Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors
Abstract
Background: Men with localized prostate carcinoma are faced with important treatment decisions, and quality of life (QoL) information has become a crucial element of decision making. The first objective of this study was to compare the early, health-related QoL (HRQoL) of men with localized prostate carcinoma who were treated with radical prostatectomy, external beam radiotherapy, or brachytherapy. A second objective was to identify demographic and psychosocial variables that predict HRQoL.
Methods: Two-hundred fifty-six men with localized prostate carcinoma were interviewed within 7 weeks of treatment initiation. The interview included measures of prostate-specific HRQoL (the University of California-Los Angeles Prostate Cancer Index), general HRQoL (the SF-36), and psychosocial variables.
Results: After adjusting for covariates, treatment group differences were found for both prostate specific HRQoL and general HRQoL. Men who underwent prostatectomy reported more urinary and sexual problems and more general physical dysfunction compared with men who were treated with either form of radiation therapy. Men who were treated with brachytherapy reported the fewest problems in sexual function and the least general physical dysfunction. Few treatment group differences were found in mental functioning. Both demographic factors and psychosocial factors predicted HRQoL. Older men and African-American men reported more physical problems than younger men and Caucasian men, respectively. A supportive social environment, high self-efficacy, and high self-esteem were predictive of better HRQoL.
Conclusions: Shortly after undergoing treatment for localized prostate carcinoma, men who underwent radical prostatectomy, older men, and African-American men are at heightened risk for experiencing prostate-specific and general deficits in HRQoL. Having psychosocial resources from which to draw may enhance HRQoL.
Copyright 2001 American Cancer Society.
Figures

Similar articles
-
Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.Eur Urol. 2015 Oct;68(4):600-8. doi: 10.1016/j.eururo.2014.08.074. Epub 2014 Sep 18. Eur Urol. 2015. PMID: 25242555
-
Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.Health Qual Life Outcomes. 2019 Jan 14;17(1):11. doi: 10.1186/s12955-019-1082-4. Health Qual Life Outcomes. 2019. PMID: 30642340 Free PMC article.
-
Effect of treatment on quality of life among men with clinically localized prostate cancer.Med Care. 2001 Mar;39(3):243-53. doi: 10.1097/00005650-200103000-00005. Med Care. 2001. PMID: 11242319
-
The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.Urology. 2001 Aug;58(2 Suppl 1):94-100. doi: 10.1016/s0090-4295(01)01250-x. Urology. 2001. PMID: 11502459 Review.
-
Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.Health Qual Life Outcomes. 2018 Jan 22;16(1):21. doi: 10.1186/s12955-018-0844-8. Health Qual Life Outcomes. 2018. PMID: 29357874 Free PMC article. Review.
Cited by
-
Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol.BMJ Open. 2022 Feb 21;12(2):e056675. doi: 10.1136/bmjopen-2021-056675. BMJ Open. 2022. PMID: 35190441 Free PMC article.
-
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program.J Clin Oncol. 2010 Jan 10;28(2):292-8. doi: 10.1200/JCO.2009.22.5011. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933917 Free PMC article.
-
Avoidant coping and self-efficacy mediate relationships between perceived social constraints and symptoms among long-term breast cancer survivors.Psychooncology. 2017 Jul;26(7):982-990. doi: 10.1002/pon.4119. Epub 2016 Mar 10. Psychooncology. 2017. PMID: 26969374 Free PMC article.
-
Race, healthcare access and physician trust among prostate cancer patients.Cancer Causes Control. 2010 Jan;21(1):31-40. doi: 10.1007/s10552-009-9431-y. Epub 2009 Sep 24. Cancer Causes Control. 2010. PMID: 19777359 Free PMC article.
-
Stress and self-efficacy predict psychological adjustment at diagnosis of prostate cancer.Sci Rep. 2014 Jul 4;4:5569. doi: 10.1038/srep05569. Sci Rep. 2014. PMID: 24993798 Free PMC article.
References
-
- American Cancer Society . Cancer facts and figures 2001. American Cancer Society; Atlanta: 2001.
-
- Hanks GE. Radiotherapy or surgery for prostate cancer? Ten and fifteen-year results of external beam therapy. Acta Oncol. 1991;30:231–7. - PubMed
-
- Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242–8. - PubMed
-
- Lu-Yao GL, Yao S-L. Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet. 1997;349:906–10. - PubMed
-
- Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–35. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical